Working… Menu

Efficacy and Safety of Low-dose IL-2 in Patients With SLE: a Multicenter, Randomised, Placebo-controlled Trial

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT04077684
Recruitment Status : Recruiting
First Posted : September 4, 2019
Last Update Posted : March 27, 2020
Information provided by (Responsible Party):
Zhanguo Li, Peking University People's Hospital

No Study Results Posted on for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : August 31, 2024
Estimated Study Completion Date : December 31, 2024